Skip Navigation


Rheumatology Advance Access originally published online on August 27, 2007
Rheumatology 2007 46(10):1538-1546; doi:10.1093/rheumatology/kem198
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
46/10/1538    most recent
kem198v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Isomäki, P.
Right arrow Articles by Silvennoinen, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Isomäki, P.
Right arrow Articles by Silvennoinen, O.
Related Collections
Right arrow Rheumatoid Arthritis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The expression of SOCS is altered in rheumatoid arthritis

P. Isomäki1,2, T. Alanärä1, P. Isohanni1, A. Lagerstedt3, M. Korpela2, T. Moilanen6, T. Visakorpi1,4 and O. Silvennoinen1,5

1Institute of Medical Technology, University of Tampere, 2Department of Internal Medicine, Division of Rheumatology, 3Department of Pathology, 4Laboratory Centre, 5Department of Clinical Microbiology, Tampere University Hospital and 6Coxa, Hospital for Joint Replacement, Tampere, Finland.

Correspondence to: P. Isomäki, MD PhD, Department of Molecular Immunology, Institute of Medical Technology, Biokatu 8, 33014 Tampere University, Tampere, Finland. E-mail: pia.isomaki{at}uta.fi


   Abstract

Objectives. Cytokines play a key pathogenic role in rheumatoid arthritis (RA). Several cytokines signal through the JAK-STAT pathway, which is negatively regulated by the suppressors of cytokine signalling (SOCS) proteins. Since SOCS protein levels can profoundly modulate cellular responses to cytokines, we have investigated their expression in chronic RA.

Methods. The levels of SOCS1–3 and CIS1 mRNA in peripheral blood (PB) and synovial fluid (SF) mononuclear cells (MCs), purified T cells and monocytes from RA patients and healthy volunteers were studied using quantitative reverse transcriptase polymerase chain reaction (RT-PCR). SOCS mRNA and protein expression in synovial tissues were examined by RT-PCR and immunohistochemistry.

Results. The levels of SOCS1 and SOCS3 were significantly increased in PBMCs from RA patients when compared with healthy volunteers. These differences were mainly due to up-regulation of SOCS1 in PB T cells and of SOCS3 in PB monocytes. In addition, SOCS2 was up-regulated in PB T cells. Interestingly, SF T cells expressed lower and SF macrophages higher levels of SOCS molecules than their PB counterparts. Similarly, while a significant portion of macrophages in synovial tissues expressed SOCS1 and SOCS3 proteins, the majority of T cells remained SOCS negative. Finally, SOCS1 was up-regulated in the synovial membranes from patients with RA when compared with osteoarthritis.

Conclusions. SOCS expression levels are profoundly altered in RA, and the profile of SOCS expression is dependent on both the cell type as well as the cellular compartment.

KEY WORDS: Rheumatoid arthritis, Cytokines, Signal transduction, JAK-STAT pathway, SOCS proteins

Submitted 4 February 2007; revised version accepted 18 June 2007.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
A. Rahman
Regulators of cytokine signalling in rheumatoid arthritis
Rheumatology, December 1, 2007; 46(12): 1745 - 1746.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.